Biocryst Pharmaceuticals Stock Widgets and Gadgets
| BCRX Stock | USD 4.58 0.03 0.65% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- BCRX BioCryst Pharmaceuticals
- Latest BioCryst Announces Approval of ORLADEYO by the Brazilian Health Regulatory Agency
- BCRX 4.58 -0.03
- Low 4.57
- High 4.79
- Alpha -0.56
- Beta 2.57
- Return On Equity -19.25
- Return On Asset -0.12
- Profit Margin (0.68) %
- Operating Margin (0.40) %
- Current Valuation 1.41 B
- Shares Outstanding 206.15 M
- Shares Owned By Insiders 1.21 %
- Shares Owned By Institutions 88.11 %
- Number Of Shares Shorted 32.25 M
- Price To Earning (7.11) X
- Price To Book 56.59 X
- Price To Sales 2.97 X
- Revenue 331.41 M
- Gross Profit 10.94 M
- EBITDA (102.05 M)
- Net Income (226.54 M)
- Cash And Equivalents 417.48 M
- Cash Per Share 2.24 X
- Total Debt 848.71 M
- Debt To Equity 2.40 %
- Current Ratio 5.19 X
- Book Value Per Share (2.21) X
- Cash Flow From Operations (95.14 M)
- Short Ratio 9.45 X
- Earnings Per Share (1.18) X
- Price To Earnings To Growth (0.28) X
- Target Price 13.82
- Number Of Employees 536
- Beta 1.93
- Market Capitalization 951.38 M
- Total Asset 516.96 M
- Retained Earnings (1.68 B)
- Working Capital 345.98 M
- Current Asset 65.99 M
- Current Liabilities 64.45 M
- Net Asset 516.96 M
- Accumulation Distribution 0.0459
- Daily Balance Of Power (0.14)
- Rate Of Daily Change 0.99
- Day Median Price 4.68
- Day Typical Price 4.65
- Market Facilitation Index 0.22
- Price Action Indicator (0.12)
- Period Momentum Indicator (0.03)
Market Snapshot Widget Example
DAX Index Germany | 17,837 0.38 | |
Taiwan Weighted Taiwan | 20,301 0.43 | |
PSI 20 Stock Portugal | 6,328 1.50 | |
CROBEX Croatia | 2,803 0.35 | |
Budapest SE Hungary | 65,674 0.67 | |
IDX 30 Jakarta Indonesia | 474.44 0.75 | |
ISEQ 20 Price Ireland | 1,628 0.48 | |
NYSE Comp USA | 17,388 0.09 | |
Tel Aviv 35 Israel | 1,912 1.29 | |
Coreshares Index Tracker South Afric | 1,030 0.88 | |
IPC MEXICO Mexico | 55,739 0.11 | |
KL Technology Malaysia | 63.89 0.14 | |
IBEX 35 Index Spain | 10,765 1.23 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,538 0.87 | |
SPASX Dividend Opportunities Australia | 1,661 0.59 | |
HNX 30 Vietnam | 484.87 2.28 | |
Bucharest BET-NG Romania | 1,207 0.53 | |
AMS Small Cap Netherlands | 1,208 0.74 | |
Oslo Exchange Mutual Norway | 1,291 0.38 | |
BEL Small Belgium | 8,962 0.02 | |
RTSI Index Russia | 1,160 0.54 | |
Basic Materials Brazil | 5,868 0.0041 | |
Swiss Leader Price Switzerland | 1,837 0.12 | |
Fondo Mutuo ETF Chile | 1,428 0.94 | |
Athens General Comp Greece | 1,381 1.14 | |
Stock Exchange Of Thailand | 1,361 0.43 | |
PX Prague Stock Czech Repub | 1,548 0.04 | |
THE PHILIPPINE STOCK Philippines | 6,523 1.13 | |
WIG 30 Poland | 3,051 1.24 | |
BIST Electricity Turkey | 583.83 0.78 |
Investing Ideas
In addition to having BioCryst Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare BioCryst Pharmaceuticals
Compare BioCryst Pharmaceuticals To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioCryst Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy BioCryst Stock please use our How to Invest in BioCryst Pharmaceuticals guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for BioCryst Stock analysis
When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is BioCryst Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioCryst Pharmaceuticals. If investors know BioCryst will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioCryst Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.18) | Revenue Per Share 1.724 | Quarterly Revenue Growth 0.174 | Return On Assets (0.12) | Return On Equity (19.25) |
The market value of BioCryst Pharmaceuticals is measured differently than its book value, which is the value of BioCryst that is recorded on the company's balance sheet. Investors also form their own opinion of BioCryst Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is BioCryst Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioCryst Pharmaceuticals' market value can be influenced by many factors that don't directly affect BioCryst Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioCryst Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioCryst Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioCryst Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.